Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Boghean

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Developmental Psychobiology|March 14, 2024
A dog's life: Early life histories influence methylation of glucocorticoid (NR3C1) and oxytocin (OXTR) receptor genes, cortisol levels, and attachment stylesSamantha L Awalt, Lidia Boghean, David Klinkebiel, et al.
Cancers|November 13, 2021
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent KinaseSandeep Rana, Jayapal Reddy Mallareddy, Sarbjit Singh, et al.
Molecules (Basel, Switzerland)|May 14, 2025
A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the NetworkLidia Boghean, Sarbjit Singh, Kiran K Mangalaparthi, et al.
Elife|April 23, 2021
Co-regulation and function of <i>FOXM1</i>/<i>RHNO1</i> bidirectional genes in cancerCarter J Barger, Linda Chee, Mustafa Albahrani, et al.
RSC Advances|April 4, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growthJohn Victor Napoleon, Satish Sagar, Sydney P Kubica, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Developmental Psychobiology|March 14, 2024
A dog's life: Early life histories influence methylation of glucocorticoid (NR3C1) and oxytocin (OXTR) receptor genes, cortisol levels, and attachment stylesSamantha L Awalt, Lidia Boghean, David Klinkebiel, et al.
Cancers|November 13, 2021
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent KinaseSandeep Rana, Jayapal Reddy Mallareddy, Sarbjit Singh, et al.
Molecules (Basel, Switzerland)|May 14, 2025
A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the NetworkLidia Boghean, Sarbjit Singh, Kiran K Mangalaparthi, et al.
Elife|April 23, 2021
Co-regulation and function of <i>FOXM1</i>/<i>RHNO1</i> bidirectional genes in cancerCarter J Barger, Linda Chee, Mustafa Albahrani, et al.
RSC Advances|April 4, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growthJohn Victor Napoleon, Satish Sagar, Sydney P Kubica, et al.
Pageof 1